Three organisations from across the Highlands and Islands have teamed up in a new collaboration to boost life sciences in the region. Highlands and Islands Enterprise (HIE), the University of the Highlands and Islands, and NHS Highland have signed a memorandum of understanding (MoU) as they progress joint initiatives on Inverness Campus. These teams will focus on key regional themes such as remote and rural...
By Dave Tudor, Chair of Life Sciences Scotland Industry Leadership Group Over the centuries Scotland has played a significant role in medical advancements and scientific innovations. But these aren’t confined to the past; this is Scotland’s future through the work and growth of Scotland’s life sciences sector. Scotland is a centre of life sciences excellence from the cloning of Dolly the sheep to advancements in...
The Scotsman Life Sciences Conference took place on the 21st November at the Technology and Innovation Centre, University of Strathclyde. Delegates from across the sector gathered to discuss the key actions required to achieve the sector’s ambitious strategy of delivering turnover of £8billion by 2025. The conference provided an invaluable opportunity to understand the key challenges for companies within the sector. Key discussion points covered...
I am writing on behalf of Life Sciences Scotland, the Industry Leadership group for Life Sciences in Scotland, to outline the critical areas we believe need to be addressed as the UK negotiates its exit from the European Union. The Scottish life sciences sector employs 37,000 people across some 700 organisations. Companies in the sector contribute more than £4.2bn turnover and about £2bn gross value...
Scotland’s wealth of experience, knowledge and capabilities in life and chemical sciences is now at your fingertips with the Life & Chemical Sciences company directory. This new interactive visual interface offers a gateway to over 1000 companies and organisations (academic organisations, research centres and trade associations) across the breadth of the life and chemical sciences sector in Scotland. This searchable user friendly tool allows visitors to...
Concept Life Sciences’ recent acquisition of Aquila BioMedical has quickly produced a return—an extended contract with Macrophage Pharma to support its preclinical immuno-oncology programs. Aquila will run a few in vitro, in vivo and ex vivo analyses to help Macrophage decide on the best candidate to enter the clinic. U.K.-based Macrophage targets cancer with its proprietary Esterase Sensitive Motif (ESM) technology, which delivers small-molecule drugs...